Tensentric

Tensentric is a contract development and manufacturing organization (CDMO) specializing in medical devices, in-vitro diagnostics (IVD), and life science research tools. Founded in 2009 and headquartered in Boulder, Colorado, the company provides end-to-end services ranging from early-stage concept development and human factors engineering to prototyping, validation, and low-to-medium volume manufacturing. Tensentric operates under an ISO 13485 certified quality management system, serving clients across medical technology, cell and gene therapy bioprocessing, and molecular diagnostics. In February 2022, the company was acquired by private equity firm GenNx360 Capital Partners to accelerate its commercial and operational growth.